Fig. 1From: Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s diseaseCSF analyte levels (Z scores) for the combined cohort of normal cognition without CSF biomarkers consistent with Alzheimer’s disease (NC–) and Alzheimer’s disease (AD) dementia subjects. To account for inter-center variability, a center-specific Z score was calculated for each analyte by grouping NC– and AD dementia subjects together to calculate the group mean and standard deviation. Student’s t tests were then used to compare the Z scores of NC– and AD dementia subjects across the three centers, with FDR < 5%. Bars represent median and interquartile ranges, and the unadjusted p values are shown. Fabp3 fatty acid binding protein 3, IL interleukin, MCP-1 monocyte chemotactic protein 1, NfL neurofilament light chain, TNF tumor necrosis factor, YKL40 chitinase-3-like protein 1Back to article page